Correlation Between CytomX Therapeutics and Terns Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both CytomX Therapeutics and Terns Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CytomX Therapeutics and Terns Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between CytomX Therapeutics and Terns Pharmaceuticals, you can compare the effects of market volatilities on CytomX Therapeutics and Terns Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CytomX Therapeutics with a short position of Terns Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of CytomX Therapeutics and Terns Pharmaceuticals.
Diversification Opportunities for CytomX Therapeutics and Terns Pharmaceuticals
0.79 | Correlation Coefficient |
Poor diversification
The 3 months correlation between CytomX and Terns is 0.79. Overlapping area represents the amount of risk that can be diversified away by holding CytomX Therapeutics and Terns Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Terns Pharmaceuticals and CytomX Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CytomX Therapeutics are associated (or correlated) with Terns Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Terns Pharmaceuticals has no effect on the direction of CytomX Therapeutics i.e., CytomX Therapeutics and Terns Pharmaceuticals go up and down completely randomly.
Pair Corralation between CytomX Therapeutics and Terns Pharmaceuticals
Given the investment horizon of 90 days CytomX Therapeutics is expected to generate 0.73 times more return on investment than Terns Pharmaceuticals. However, CytomX Therapeutics is 1.37 times less risky than Terns Pharmaceuticals. It trades about -0.04 of its potential returns per unit of risk. Terns Pharmaceuticals is currently generating about -0.07 per unit of risk. If you would invest 116.00 in CytomX Therapeutics on August 28, 2024 and sell it today you would lose (14.00) from holding CytomX Therapeutics or give up 12.07% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 98.44% |
| Values | Daily Returns |
CytomX Therapeutics vs. Terns Pharmaceuticals
Performance |
| Timeline |
| CytomX Therapeutics |
| Terns Pharmaceuticals |
CytomX Therapeutics and Terns Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with CytomX Therapeutics and Terns Pharmaceuticals
The main advantage of trading using opposite CytomX Therapeutics and Terns Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CytomX Therapeutics position performs unexpectedly, Terns Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Terns Pharmaceuticals will offset losses from the drop in Terns Pharmaceuticals' long position.| CytomX Therapeutics vs. Eliem Therapeutics | CytomX Therapeutics vs. Scpharmaceuticals | CytomX Therapeutics vs. Milestone Pharmaceuticals | CytomX Therapeutics vs. Seres Therapeutics |
| Terns Pharmaceuticals vs. Capricor Therapeutics | Terns Pharmaceuticals vs. Soleno Therapeutics | Terns Pharmaceuticals vs. Bio Path Holdings | Terns Pharmaceuticals vs. Moleculin Biotech |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Complementary Tools
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |